A multinational, drug utilization study of lipegfilgrastim use in real-world setting in Europe.

Sigal KaplanDana Ilic BogojevicCarolyn RainvilleNicholas Gross

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2022)

Using real-world data, these findings confirm the low rate of lipegfilgrastim off-label use as reported in a preceding feasibility study, indicating very high adherence to the approved indication.

Keyphrases

electronic health record
big data
type diabetes
metabolic syndrome
weight loss